The HemoCue® Glucose 201+ System puts lab-quality answers in your hands when they’re needed most – at the point of care. Not only does the unique microcuvette technology enable accurate result reading in only three simple steps, it also reduces contamination risk.
Key benefits
Used in screening, monitoring and as an aid in the diagnosis of diabetes mellitus, the HemoCue® Glucose 201+ System enables you to make the right decision at the point of care while reducing margins of error and risk of infection.
02 Precise monitoring for better glycemic control
03 Possible to detect hypoglycemia in newborns
04 Factory calibrated analyzers means no need to recalibrate
05 Portable and battery-operated system means ideal for mobile settings
06 Microcuvette technology means reduced risk of infection spreading
System specifications
Principle
Modified glucose degydrogenase in which the total amount of glucose is measured at the end point photometrically
Calibration
Factory calibrated and traceable to the ID GC-MS method; needs no further calibration and no coding
Power
AC Adapter or 4 AA batteries
Interface
Printer and HemoCue® Basic Connect including optional barcode scanner. Data transfer using Bluetooth® technology is possible via HemoCue® BT Connect (accessory)
Measurement range
Plasma equivalent values: 0.61-24.6 mmol/L (11-444 mg/dL)
Whole blood values: 0.55-22.2 mmol/L (10-400 mg/dL)
Operating temperature
15-30°C (59-86°F)
Storage temperature
Analyzer: 0-50°C (32-122°F)
Microcuvettes: unopened below 8°C (46°F) (incl. storage in a freezer), room temperature for up to 3 days; one-month open vial stability